HB 4423 requires the Oklahoma Health Care Authority to verify the immigration status of all Medicaid applicants using the federal SAVE system (or its successor) before approving benefits. It specifically mandates that the Authority notify U.S. Immigration and Customs Enforcement (ICE) if an applicant's status cannot be verified as lawful. This applies to all applicants, including adults applying for child-only Medicaid benefits on behalf of a child. The bill takes effect October 1, 2026, and does not change Medicaid eligibility criteria but adds a verification step for immigration status.
HB 3644 (the Blake Burgess Act) requires hospitals with emergency departments and ambulatory surgical centers to implement standardized VTE (venous thromboembolism, or blood clot in veins) risk assessments for patients using nationally recognized tools and provide annual training to non-physician clinical staff. It mandates a statewide VTE registry managed by a private, nonprofit entity meeting specific criteria, which hospitals must report to starting July 2027 with data including patient age, zip code, sex, diagnosis details, and treatment. The registry collects information to improve VTE care quality, monitor outcomes, and inform state health reports, with hospitals required to submit data on VTE incidence, patient demographics, and treatment. The law directly affects hospitals, ambulatory surgical centers, and their clinical staff through new screening, training, and reporting obligations.
HB 1168 makes it a felony to knowingly deliver or possess abortion-inducing drugs (like misoprostol or methotrexate) with the intent of causing an abortion, punishable by up to $100,000 in fines or 10 years in prison. It directly affects individuals who provide such drugs for non-exceptional purposes, including off-label use for abortion. Key exceptions include pharmacists, manufacturers, and distributors acting within lawful medical practices, as well as preventive contraception used as directed by manufacturers. The law does not restrict treatment for ectopic pregnancies, miscarriages, or medical uses of drugs like chemotherapy.
SB 1255 requires Oklahoma's Department of Corrections medical director to certify qualifying medical conditions and request the Pardon and Parole Board to place eligible inmates on a special docket for compassionate parole consideration. It directly affects inmates with specific terminal or debilitating conditions like dementia, cancer, HIV/AIDS, or conditions causing near-death (six-month life expectancy), or those unable to perform basic self-care. The bill bypasses the standard two-step parole hearing process for these inmates and mandates that at least three Board members must concur to consider medical parole. The Board must document concurrence in meeting minutes, and parolees may face revocation if their medical condition poses public safety risks.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
HB 2144 creates a new legal cause of action for Oklahoma insurance policyholders and third parties who suffer unreasonable delays or denials of benefits by insurers, defining "bad faith" as violating an insurer’s duty of good faith and fair dealing. It prohibits insurers from including clauses reserving discretion to interpret policies or deny claims, eliminates the need to exhaust administrative remedies before suing, and guarantees jury trials for bad faith claims. The bill applies to all insurance policies issued in Oklahoma (including health, disability, and employee benefits), directly affecting insured individuals, businesses, and third parties who rely on insurance contracts. Key provisions clarify that insurers must pay valid claims promptly, and claimants can seek damages for unreasonable refusals or delays without first appealing to the Oklahoma Insurance Department.
SB 207 establishes the Oklahoma Rare Disease Advisory Council within the State Department of Health to address the needs of Oklahomans living with rare diseases (defined as conditions affecting fewer than 200,000 people nationally). The Council, composed of 13 diverse members including patients, caregivers, healthcare providers, researchers, and industry representatives, will conduct public hearings, develop policy recommendations, and create emergency care protocols to improve access to specialists, diagnostics, and equitable treatment. The bill also modifies Oklahoma’s newborn screening program to require an educational initiative for treatable genetic disorders, aiming to prevent intellectual disabilities and reduce infant mortality through early intervention. This legislation directly affects rare disease patients, their families, healthcare providers, and state agencies responsible for public health programs in Oklahoma.
SB 804 requires Oklahoma assisted living centers to establish an internal quality assurance committee that meets quarterly. The committee must monitor incidents, resident satisfaction, and care quality - especially medication administration - and recommend policies, with membership including a registered nurse, administrator, direct care staff, and pharmacist as needed. The bill also updates existing rules to mandate monthly medication reviews by nurses/pharmacists, standardized resident screening, posting inspection results online, and individualized care plans. These changes directly affect all licensed assisted living centers in Oklahoma, effective November 1, 2025.
HB 2785 requires Oklahoma's Office of Management and Enterprise Services (OMES) to implement stricter budget oversight for the Department of Mental Health and Substance Abuse Services. It mandates OMES to review agency budgets against actual spending before releasing funds, prohibit contracts without clear cost limits, restrict multi-year contract encumbrances to current-year funds, and block payments for unapproved expenses. The bill also requires OMES to report monthly revenue and spending status to the Governor, legislature leadership, and relevant committees. This directly affects state budget management for mental health services by adding specific financial controls to prevent overspending. The law takes immediate effect due to an emergency declaration.
SB 176 requires health insurance plans to cover certain prescription drugs that were previously not included in standard coverage. It directly affects health insurance providers and policyholders by mandating this specific coverage for eligible medications. The key provision is a new requirement for all health benefit plans to include these designated prescriptions without prior authorization or excessive cost-sharing. The law became effective on May 29, 2025, after the Governor did not sign it.
